Comments
Loading...
ArriVent BioPharma (NASDAQ:AVBP) Stock, Earnings Estimates, EPS, And Revenue
ArriVent BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 2
EPS Estimate
$-1.100
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of ArriVent BioPharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
ArriVent BioPharma (AVBP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.61 | $-0.82 | 25.6 % |
| Q2 | 2024-08-14 | $-0.65 | $-0.54 | -20.4 % |
| Q1 | 2024-05-08 | $-0.70 | $-1.05 | 33.3 % |
ArriVent BioPharma (AVBP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?
ArriVent BioPharma (AVBP) is scheduled to report earnings on February 2, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for ArriVent BioPharma (NASDAQ:AVBP)?
The Actual EPS was $-0.61, which beat the estimate of $-0.82.
What were ArriVent BioPharma’s (NASDAQ:AVBP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.